Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01045668 · ClinicalTrials.gov registry record · Phase 3
Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
A Phase 3 study of Ventricular Tachycardia, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT01045668 is a Phase 3 study of Ventricular Tachycardia that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 120 participants, below the 284-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01045668, a Phase 3 study of Ventricular Tachycardia, has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess whether a combined technique of substrate ablation and ablation of the clinically presenting VT at the site of early activation is superior to ablation of the clinically presenting VT alone, in enhancing long-term success of VT ablation.
Conditions Studied
Interventions
- PROCEDURE Radiofrequency Catheter Ablation (RFCA)
Study Locations (1)
Texas
- St.David's Medical Center - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01045668
The ClinicalTrials.gov registry entry for NCT01045668 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (58% lower). The listed sponsor is Texas Cardiac Arrhythmia Research Foundation, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Catheter Ablation (RFCA) is the first listed.
NCT01045668 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01045668 about?
NCT01045668 is a clinical study titled "Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation". This study aims to assess whether a combined technique of substrate ablation and ablation of the clinically presenting VT at the site of early activation is superior to ablation of the clinically presenting VT alone, in enhancing long-term success of VT ablation.
What is the current status of trial NCT01045668?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2010-01. Estimated completion is 2014-07.
What conditions does trial NCT01045668 study?
This clinical trial studies the following conditions: Ventricular Tachycardia.
What interventions are being tested in trial NCT01045668?
The interventions under investigation include: Radiofrequency Catheter Ablation (RFCA) (PROCEDURE).
Who is sponsoring clinical trial NCT01045668?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01045668 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
RECRUITING
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.